source
- Pfizer strikes Innovent deal worth up to $10.5B for a dozen cancer programsOn the eve of this year’s ASCO annual meeting, Pfizer said it is teaming up with China’s Innovent Biologics to advance a portfolio of 12 early-stage antibody-drug conjugates and multi-specific anti…Endpoints · 2mo ago↗ source
- Lilly obesity meds Foundayo and Zepbound to gain CVS coverageEli Lilly’s flagship obesity medications will be included in CVS Caremark formularies, likely boosting sales in the most competitive commercial drug market. The company announced Thursday that its…Endpoints · 2mo ago↗ source
- GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’The findings supporting bepirovirsen were deemed a “historic moment” by physicians and validate a drug that has “clear blockbuster potential,” according to one analyst.